Pakistan Competition Commission conditionally approves GSK’s purchase of Novartis’ vaccines business
MLex Summary: The Competition Commission of Pakistan said it has conditionally approved the proposed acquisition of Novartis' global vaccines business, which doesn’t include the influenza business, by GlaxoSmithKline. GSK and Novartis overlap...To view the full article, register now.
Already a subscriber? Click here to view full article